Our Pricing

First Week Changes: What Happens Days 1-7

Published on: June 03, 2026

Understanding weight loss first week changes UK patients experience helps set realistic expectations when starting prescription medication. At Cured Pharmacy, our UK-registered clinical team guides thousands of patients through their first seven days, explaining the biological adjustments, common side effects, and early indicators that your treatment is working as intended.

What Happens in Your Body During the First Week

When you begin a GLP-1 receptor agonist like Mounjaro or Wegovy, the medication immediately starts mimicking natural gut hormones that regulate appetite and blood sugar [1]. Within 24-48 hours, most patients notice reduced hunger signals as the medication binds to receptors in the brain's appetite control centres. This isn't willpower — it's a measurable neurological response documented across multiple clinical trials.

Tirzepatide, the active ingredient in Mounjaro, works through dual GIP/GLP-1 pathways, producing a more pronounced effect than single-pathway medications [2]. During week one, your pancreas begins releasing insulin more efficiently in response to food, whilst gastric emptying slows by approximately 30-40%, meaning you feel fuller for longer after smaller portions.

The initial dose is intentionally low to allow your digestive system to adapt gradually. In the SURPASS-1 trial, researchers found that starting with 2.5mg tirzepatide minimised discontinuation rates whilst still initiating the metabolic changes needed for sustained weight reduction [2].

Hormonal Adjustments in Days 1-3

The first 72 hours involve the most significant hormonal recalibration. GLP-1 receptor activation triggers a cascade of metabolic changes: reduced glucagon secretion, enhanced insulin sensitivity, and decreased ghrelin (the 'hunger hormone') production. These aren't side effects — they're the intended therapeutic mechanisms that make weight loss possible without constant hunger.

Common Physical Sensations During Week One

Approximately 60-70% of patients starting GLP-1 medications experience mild gastrointestinal adjustments during the first week [3]. These typically include slight nausea (usually worse 2-3 hours after injection), reduced appetite, occasional bloating, and changes in bowel habits. In clinical practice at Cured Pharmacy, Superintendent Pharmacist Tarun Kumar (GPhC 2233073) advises patients that these sensations usually peak around day 3-4 and diminish significantly by day 7.

Nausea, when it occurs, is generally mild and manageable with simple strategies: eating smaller portions, avoiding high-fat meals, staying hydrated, and taking your injection in the evening rather than morning. Severe nausea requiring treatment discontinuation occurred in less than 5% of trial participants [1][3].

Some patients report feeling unusually tired during days 2-5 as their body adjusts to lower calorie intake and metabolic changes. This typically resolves within the first week as your energy regulation stabilises. If fatigue persists beyond week one, your UK prescriber may adjust your dosing schedule or investigate other factors.

Managing Side Effects in the First Seven Days

The MHRA-licensed starting doses for weight loss medications are specifically designed to minimise side effects whilst initiating therapeutic action. Mounjaro begins at 2.5mg weekly, Wegovy at 0.25mg weekly, and Saxenda at 0.6mg daily, with gradual escalation over subsequent weeks [4].

If you experience nausea, eat smaller meals every 3-4 hours rather than three large meals. Cold or room-temperature foods are often better tolerated than hot meals during the adjustment period. Ginger tea, plain crackers, and protein-rich snacks help stabilise blood sugar and reduce queasiness.

Constipation affects approximately 30% of patients in week one due to slower gastric emptying [3]. Increase fibre intake gradually, drink at least 2 litres of water daily, and consider a gentle fibre supplement if needed. Contact your prescriber if constipation persists beyond five days or becomes uncomfortable.

When to Contact Your Prescriber

Whilst mild side effects are expected, contact your UK clinical team immediately if you experience severe persistent vomiting, signs of pancreatitis (severe upper abdominal pain radiating to your back), allergic reactions, or visual changes. These occur rarely but require prompt medical assessment. All patients at Cured Pharmacy receive direct access to our clinical team throughout their treatment journey.

Realistic Weight Changes in Days 1-7

During the first week on weight loss medication, most patients lose 0.5-2kg, though individual variation is significant [1][2]. This initial reduction is primarily fluid loss as your body adjusts to lower sodium intake and reduced glycogen stores. Meaningful fat loss typically begins in weeks 2-4 as the medication reaches steady-state levels in your system.

The STEP trials for semaglutide showed minimal weight change in week one, with substantial reductions beginning around week 4 and continuing progressively over 68 weeks [5]. Similarly, the SURMOUNT trials for tirzepatide demonstrated that early responders and late responders achieved comparable outcomes by month 6, indicating that first-week results don't predict long-term success.

Some patients notice no scale change in week one but report significant appetite reduction and easier portion control. These behavioural changes are valuable early indicators that the medication is working, even before measurable weight loss occurs. Focus on how you feel rather than daily weigh-ins during the adjustment period.

Comparing First Week Experiences Across Medications

Different weight loss medications produce varying first-week experiences based on their pharmacological profiles. Mounjaro (tirzepatide) typically causes slightly more appetite suppression in week one due to its dual GIP/GLP-1 action, whilst Wegovy (semaglutide) and Saxenda (liraglutide) have comparable early tolerability profiles [2][5].

Saxenda requires daily injections, meaning the dose builds more gradually in your system compared to weekly injections. Some patients find this produces gentler side effects, whilst others prefer the convenience of once-weekly administration with Mounjaro or Wegovy.

Orlistat-based medications like Xenical and Alli work through an entirely different mechanism — blocking fat absorption in the intestine rather than affecting appetite hormones. First-week experiences with orlistat involve adapting to a low-fat diet to avoid gastrointestinal side effects, rather than managing appetite changes.

Choosing Your Starting Treatment

Your UK prescriber will recommend a specific medication based on your medical history, weight loss goals, previous medication responses, and lifestyle factors. All prescription weight loss treatments available through Cured Pharmacy require online clinical assessment to ensure safety and appropriateness. Our transparent pricing model shows costs upfront, with Mounjaro starting from £135.00, allowing you to make informed decisions before your consultation.

Optimising Your First Week for Long-Term Success

The habits you establish during week one significantly influence your long-term outcomes. Keep a simple symptom diary noting appetite levels, side effects, meal sizes, and energy levels. This information helps your prescriber optimise your dosing schedule in subsequent weeks and identifies patterns that may need adjustment.

Plan your first injection for a day when you can rest if needed — many patients choose Friday evening so any side effects occur over the weekend. Have easy-to-digest foods available: plain crackers, bananas, rice, lean protein, and ginger tea. Avoid scheduling the injection before important events or travel during your first week.

Stay hydrated throughout the week, aiming for 2-3 litres of water daily. Dehydration exacerbates nausea and can cause headaches, which patients sometimes mistakenly attribute to the medication. Gentle movement like walking aids digestion and helps manage any bloating, but avoid intense exercise until you understand how your body responds to the treatment.

Remember that week one is about adjustment, not dramatic results. The clinical trials demonstrating 15-22.5% body weight reduction measured outcomes over 68-72 weeks [1][2][5]. Your first week is simply the beginning of a gradual, sustainable process guided by UK-registered healthcare professionals.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Rosenstock, J., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
3. Nauck, M. A., et al. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2020.101102 [accessed 13 August 2026]
4. Medicines and Healthcare products Regulatory Agency. (2023). Summary of Product Characteristics for Mounjaro. MHRA. Retrieved from https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency [accessed 13 August 2026]
5. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.